Showing 1481-1490 of 3201 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20551/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-7/23139/Therapeutic Review: A Host of New Treatments Emerged in 2018
https://practicaldermatology.com/topics/psoriasis/therapeutic-review-a-host-of-new-treatments-emerged-in-2018/20381/Here's a handy reference to new drugs and devices—and other key developments—this year.Expert Profiles of Fillers for Your Practice
https://practicaldermatology.com/topics/general-topics/expert-profiles-of-fillers-for-your-practice/21486/Experts discuss their experiences with various popular fillers and their benefits for patients.2019 In Review
https://practicaldermatology.com/topics/practice-management/2019-in-review/23168/A look back at approvals, data, and industry developments of the year.New in My Practice: OTC Skincare/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-skincarenew-products/23704/Best-in-Class At-Home Beauty Devices for Dermatologists
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/best-in-class-at-home-beauty-devices-for-dermatologists/20724/An experience-based assessment of a growing market segment.The Art of Patient Scheduling
https://practicaldermatology.com/topics/practice-management/the-art-of-patient-scheduling/23676/Is your patient scheduling system working as efficiently as possible? Put these five action items in place to ensure your practice is firing on all cylinders.What to Know About PA Education and Dermatology Training
https://practicaldermatology.com/topics/general-topics/what-to-know-about-pa-education-and-dermatology-training/21643/Part II of a series highlights key considerations regarding the education and training of PAs in dermatology.Understanding PML and Risks Associated with Biologic Therapies
https://practicaldermatology.com/topics/psoriasis/PD0509_10-php/22832/A swarm of controversy has enveloped biologics due to concerns about progressive multifocal leukoencephalopathy.